Information Technology Reference
In-Depth Information
syndesmophyte growth in 79 % of the patients compared to only 12 % for radio-
graphic reading. The mean 2-year change represented a 18 % increase in syndes-
mophyte volume in respect to the baseline volume. This method holds promise for
longitudinal clinical studies that need to track syndesmophyte growth.
References
1. Sieper J, Braun J, Rudwaleit M et al (2002) Ankylosing spondylitis: an overview. Ann Rheum
Dis 61(Suppl III):iii8 - iii18
2. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379 - 1390
3. Braun J, Brandt J, Listing J et al (2002) Treatment of active ankylosing spondylitis with
infliximab: a randomised controlled multicentre trial. Lancet 359:1187 - 1193
4. Davis JC, van der Heijde D, Braun J et al (2003) Recombinant human tumor necrosis factor
receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Arthritis Rheum 48(11):3230
3236
5. van der Heijde D, Kivitz A, Schiff MH et al (2006) Efficacy and safety of adalimumab in
patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind,
placebo-controlled trial. Arthritis Rheum 54(7):2136
-
2146
6. Baraliakos X, Listing J, Rudwaleit M et al (2005) Radiographic progression in patients with
ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha
antibody in
-
1466
7. Baraliakos X, Listing J, Brandt J et al (2007) Radiographic progression in patients with
ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody in
fl
iximab. Ann Rheum Dis 64:1462
-
fl
iximab.
1453
8. van der Heijde D, Landew
Rheumatology 46:1450
-
R, Baraliakos X et al (2008) Radiographic findings following two
years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum
58:3063 - 3070
9. van der Heijde D, Landew é R, Einstein S et al (2008) Radiographic progression of ankylosing
spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58:1324 - 1331
10. van der Heijde D, Salonen D, Weissman BN et al (2009) Assessment of radiographic
progression in the spines of patients with ankylosing spondylitis treated with adalimumab for
up to 2 years. Arthritis Res Ther 11:R127
11. Baraliakos X, Listing J, Rudwaleit M et al (2008) The relationship between in
é
ammation and
new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 10:R104
12. Bennett AN, McGonagle D, O
fl
Connor P et al (2008) Severity of baseline magnetic resonance
imaging-evident sacroiliitis and HLA
'
ammatory back pain predict
radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58(11):
3413
B27 status in early in
fl
-
3418
13. Maksymowych WP, Chiowchanwisawakit P, Clare T et al (2009) In
-
ammatory lesions of the
spine on magnetic resonance imaging predict the development of new syndesmophytes in
ankylosing spondylitis: evidence of a relationship between in
fl
fl
ammation and new bone
102
14. Chiowchanwisawakit P, Lambert RG, Conner-Spady B et al (2011) Focal fat lesions at
vertebral corners on magnetic resonance imaging predict the development of new
syndesmophytes in ankylosing spondylitis. Arthritis Rheum 63:2215 - 2225
15. Pedersen SJ, Chiowchanwisawakit P, Lambert RG et al (2011) Resolution of inflammation
following treatment of ankylosing spondylitis is associated with new bone formation.
J Rheumatol 38:1349 - 1354
formation. Arthritis Rheum 60:93
-
Search WWH ::




Custom Search